Serum Concentration of Tranexamic Acid After Topical Administration in Massive Weight Loss Skin Reducing Surgery

NCT03101124 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Surgical Wound
Bleeding

Interventions

DRUG: Tranexamic Acid 25 mg/ml for wound surface moistening
DRUG: Tranexamic Acid 5 mg/ml as bolus in wound cavity
DRUG: Tranexamic Acid Injectable Solution

Sponsor

St. Olavs Hospital

Collaborators

[object Object]